These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16044033)

  • 21. Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats.
    Moon C; Krawczyk M; Lakatta EG; Talan MI
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):245-51. PubMed ID: 17019537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model.
    Saeed M; Watzinger N; Krombach GA; Lund GK; Wendland MF; Chujo M; Higgins CB
    Radiology; 2002 Sep; 224(3):830-7. PubMed ID: 12202722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model.
    Kellar RS; Lancaster JJ; Thai HM; Juneman E; Johnson NM; Byrne HG; Stansifer M; Arsanjani R; Baer M; Bebbington C; Flashner M; Yarranton G; Goldman S
    J Cardiovasc Pharmacol; 2011 May; 57(5):568-74. PubMed ID: 21326109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.
    Klopsch C; Furlani D; Gäbel R; Li W; Pittermann E; Ugurlucan M; Kundt G; Zingler C; Titze U; Wang W; Ong LL; Wagner K; Li RK; Ma N; Steinhoff G
    J Cell Mol Med; 2009 Apr; 13(4):664-79. PubMed ID: 19449462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion.
    Yamazaki KG; Taub PR; Barraza-Hidalgo M; Rivas MM; Zambon AC; Ceballos G; Villarreal FJ
    J Am Coll Cardiol; 2010 Jun; 55(25):2869-76. PubMed ID: 20579545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
    Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan hydrogels significantly limit left ventricular infarction and remodeling and preserve myocardial contractility.
    Henning RJ; Khan A; Jimenez E
    J Surg Res; 2016 Apr; 201(2):490-7. PubMed ID: 27020836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
    Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells.
    Prunier F; Pfister O; Hadri L; Liang L; Del Monte F; Liao R; Hajjar RJ
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H522-9. PubMed ID: 16997893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained-release erythropoietin ameliorates cardiac function in infarcted rat-heart without inducing polycythemia.
    Lin X; Fujita M; Kanemitsu N; Kimura Y; Tambara K; Premaratne GU; Nagasawa A; Ikeda T; Tabata Y; Komeda M
    Circ J; 2007 Jan; 71(1):132-7. PubMed ID: 17186991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The temporal impact of erythropoietin administration on mitochondrial function and dynamics in cardiac ischemia/reperfusion injury.
    Benjanuwattra J; Apaijai N; Chunchai T; Singhanat K; Arunsak B; Intachai K; Chattipakorn SC; Chattipakorn N
    Exp Mol Pathol; 2022 Aug; 127():104802. PubMed ID: 35679888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction.
    Orn S; Manhenke C; Anand IS; Squire I; Nagel E; Edvardsen T; Dickstein K
    Am J Cardiol; 2007 Apr; 99(8):1109-14. PubMed ID: 17437737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of erythropoietin combined with granulocyte-colony stimulating factor in the treatment of acute myocardial infarction in rats].
    Fu ZH; Dong W; Gai LY; Wang F; Ding R; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):17-22. PubMed ID: 21269949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.
    Lipsic E; van der Meer P; Henning RH; Suurmeijer AJ; Boddeus KM; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Cardiovasc Pharmacol; 2004 Oct; 44(4):473-9. PubMed ID: 15454856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the early administration of losartan on the functional and morphological aspects of postmyocardial infarction ventricular remodeling in rabbits.
    González GE; Palleiro J; Monroy S; Pérez S; Rodríguez M; Masucci A; Gelpi RJ; Morales C
    Cardiovasc Pathol; 2005; 14(2):88-95. PubMed ID: 15780800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
    van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction.
    Chandrashekhar Y; Sen S; Anway R; Shuros A; Anand I
    J Am Coll Cardiol; 2004 Jan; 43(2):295-301. PubMed ID: 14736452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.
    Prunier F; Bière L; Gilard M; Boschat J; Mouquet F; Bauchart JJ; Charbonnier B; Genée O; Guérin P; Warin-Fresse K; Durand E; Lafont A; Christiaens L; Abi-Khalil W; Delépine S; Benard T; Furber A
    Am Heart J; 2012 Feb; 163(2):200-7.e1. PubMed ID: 22305837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction.
    Tang XL; Rokosh G; Sanganalmath SK; Tokita Y; Keith MC; Shirk G; Stowers H; Hunt GN; Wu W; Dawn B; Bolli R
    Circ Heart Fail; 2015 Jul; 8(4):757-65. PubMed ID: 25995227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.